| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 1073 | 2021 |
| Oral versus intravenous antibiotics for bone and joint infection HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ... New England Journal of Medicine 380 (5), 425-436, 2019 | 817 | 2019 |
| Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ... Nature medicine 27 (12), 2127-2135, 2021 | 678 | 2021 |
| Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ... Nature 458 (7238), 641-645, 2009 | 559 | 2009 |
| Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 J Martinez-Picado, JG Prado, EE Fry, K Pfafferott, A Leslie, S Chetty, ... Journal of virology 80 (7), 3617-3623, 2006 | 553 | 2006 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 529 | 2022 |
| Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial S Ramakrishnan, DV Nicolau, B Langford, M Mahdi, H Jeffers, ... The Lancet Respiratory Medicine 9 (7), 763-772, 2021 | 474 | 2021 |
| Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta, ... Nature medicine 27 (8), 1370-1378, 2021 | 395 | 2021 |
| Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Nature Medicine 27 (2), 279-288, 2021 | 356 | 2021 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 326 | 2020 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 313 | 2021 |
| Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom J Wei, N Stoesser, PC Matthews, D Ayoubkhani, R Studley, I Bell, JI Bell, ... Nature microbiology 6 (9), 1140-1149, 2021 | 313 | 2021 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 295 | 2020 |
| Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients PA Goepfert, W Lumm, P Farmer, P Matthews, A Prendergast, JM Carlson, ... Journal of Experimental Medicine 205 (5), 1009-1017, 2008 | 265 | 2008 |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, B Angus, MA Ansari, ... Cell 185 (5), 916-938. e58, 2022 | 244 | 2022 |
| Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel ER Adams, M Ainsworth, R Anand, MI Andersson, K Auckland, JK Baillie, ... Wellcome Open Research 5, 139, 2020 | 238 | 2020 |
| Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines J Wei, KB Pouwels, N Stoesser, PC Matthews, I Diamond, R Studley, ... Nature Medicine 28 (5), 1072-1082, 2022 | 231 | 2022 |
| Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa PC Matthews, AM Geretti, PJR Goulder, P Klenerman Journal of clinical virology 61 (1), 20-33, 2014 | 228 | 2014 |
| Diagnosis and management of prosthetic joint infection PC Matthews, AR Berendt, MA McNally, I Byren Bmj 338, 2009 | 222 | 2009 |
| COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing T Peto, D Affron, B Afrough, A Agasu, M Ainsworth, A Allanson, K Allen, ... EClinicalMedicine 36, 2021 | 219 | 2021 |
Philip GoulderProfessor of Immunology University of Oxford在 paediatrics.ox.ac.uk 的电子邮件经过验证
